Results 21 to 30 of about 18,862 (133)
Management of massive haemoptysis
, 2002 Background: This study compares two management techniques in the treatment of massive haemotysis. Method: All patients with massive haemoptysis treated between January 1969 and December 1980 (group 1) were retrospectively reviewed and those ...
Adegboye, VO +3 more
core +1 more source
Postcoital Haemoptysis: A Case Report and a Review of the Literature [PDF]
, 2013 Haemoptysis is rarely reported following coitus, and cardiac decompensation has been mostly implicated in the aetiology. We present a 53-year-old Nigerian, known hypertensive diabetic woman with background ischaemic heart disease who presented with ...
Peter O. Okokhere +5 more
core +1 more source
Arthritis Care &Research, EarlyView.Objective The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.
Luca Iorio +28 more
wiley +1 more source
Massive haemoptysis from right middle lobe bronchus managed by customized silicon stents
, 2019 Massive haemoptysis is life‐threatening. Management options include pharmacological treatment, bronchial artery embolization, surgical resection, and bronchoscopic interventions.
Huiping Hu +5 more
core +1 more source
An unusual cause of haemoptysis and headache: Cryptococcosis [PDF]
, 2008 Pulmonary cryptococcosis can be clinically silent in non-HIV infected patients but can also present as nodules and masses on the chest radiograph, which can be mistaken for tuberculosis or lung cancer.
Niusha
core +1 more source
Arthritis &Rheumatology, EarlyView.Objective To assess the 2022 American College of Rheumatology (ACR)/EULAR classification criteria for antineutrophil cytoplasmic antibody–associated vasculitis (AAV) in children with chronic small‐to‐medium vessel vasculitis. Methods A cohort of 574 patients, identified by physician's diagnosis (MD‐diagnosis) in A Registry of Childhood Vasculitis, was ...
David A. Cabral +41 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim Intradermal application of lipopolysaccharide (LPS), a Toll‐like receptor 4 agonist, induces a local inflammatory response and is used as a human challenge model to evaluate the pharmacodynamics of investigational medicinal products. While currently applied in a single, parallel‐group setting, alternative within‐subject designs involving repeated ...
Alexandra A. J. Sillé +12 more
wiley +1 more source
Head &Neck, EarlyView.ABSTRACT Background Head and neck squamous cell carcinoma (HNSCC) lacks an established screening program, and most cases are diagnosed at advanced stages. Multi‐cancer early detection (MCED) blood‐based assays represent a promising approach, yet real‐world clinical experience with MCED‐identified HNSCC remains limited.
Abhinav Talwar +3 more
wiley +1 more source
Bronchoscopy in Diagnosis of Haemoptysis
, 2018 With great interest, we read the article by Torbiarczyk et al. on bronchoscopy in diagnosis of haemoptysis (Adv Respir Med. 2018; 86: 13–16) [...]
Toshihiro Shiozawa +3 more
core +1 more source
Development and Preliminary Validation of a Modified Thyroid Symptom Questionnaire (TSQ)
Head &Neck, EarlyView.ABSTRACT Background This study aimed to modify and validate the Thyroidectomy Voice and Symptom Questionnaire (TVSQ) to serve as a symptom screening tool in benign thyroid disease. Methods A 32‐item modified TVSQ was developed and administered alongside a symptom checklist to outpatients; controls were recruited to determine discriminative validity ...
Vikash Yogaraj +2 more
wiley +1 more source